Amphastar Pharmaceuticals, Inc. (AMPH) financial statements (2021 and earlier)

Company profile

Business Address 11570 SIXTH STREET
RANCHO CUCAMONGA, CA 91730
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments106858968736668
Cash and cash equivalents93748666726668
Short-term investments1312331  
Restricted cash and investments4444111
Receivables66455236273323
Inventory, net of allowances, customer advances and progress billings971116964807182
Inventory971116964807182
Deferred tax assets    20
Other undisclosed current assets710616354
Total current assets:280255220188184176198
Noncurrent Assets
Finance lease, right-of-use asset11
Operating lease, right-of-use asset2019
Property, plant and equipment260234210185153142138
Intangible assets, net (including goodwill), including:41414245504043
Goodwill4444444
Intangible assets, net (excluding goodwill)37891117738
Other undisclosed intangible assets, net (including goodwill)029292929290
Deferred income tax assets2526
Other noncurrent assets511109954
Deferred tax assets, net31283127 
Other undisclosed noncurrent assets      7
Total noncurrent assets:352332293267244214191
TOTAL ASSETS:631587514455428390389
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities96778758534738
Accounts payable24253117161410
Accrued liabilities71525641161713
Employee-related liabilities    141311
Taxes payable    833
Debt1281865118
Deferred revenue and credits  114
Deferred tax liabilities    1
Other undisclosed current liabilities4513222
Total current liabilities:1129010767616063
Noncurrent Liabilities
Long-term debt and lease obligation, including:34393241323036
Long-term debt, excluding current maturities46464946364043
Operating lease, liability1716
Other undisclosed long-term debt and lease obligation(29)(23)(17)(5)(4)(10)(7)
Liabilities, other than long-term debt1914109448
Deferred revenue and credits 012
Accounts payable and accrued liabilities5301100
Deferred tax liabilities, net111 6
Deferred income tax liabilities11
Other liabilities1399722 
Other undisclosed noncurrent liabilities1716  110
Total noncurrent liabilities:70694250383545
Total liabilities:1831591491179895108
Stockholders' equity
Stockholders' equity attributable to parent402381332337329296282
Common stock0000000
Treasury stock, value(122)(98)(75)(51)(20)(10)(0)
Additional paid in capital410367344314283248221
Accumulated other comprehensive loss(4)(5)(4)(2)(5)(2)(2)
Retained earnings1181166776716063
Stockholders' equity attributable to noncontrolling interest464632    
Total stockholders' equity:449428364337329296282
TOTAL LIABILITIES AND EQUITY:631587514455428390389

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues350322295240255252210
Revenue, net240255252210
Cost of revenue(207)(190)(188)(149)(151)(174)(159)
Gross profit:143132107911047751
Operating expenses(132)(132)(116)(92)(88)(84)(69)
Operating income (loss):11(0)(9)(1)16(7)(18)
Nonoperating income (expense)(6)60(1)3(1)(3)(0)
Investment income, nonoperating1100000
Other nonoperating income (expense)(7)59(2)30(3)0
Interest and debt expense(0)(0)(0)(1)(1)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes      1
Income (loss) from continuing operations before equity method investments, income taxes:460(10)114(11)(18)
Other undisclosed income from continuing operations before income taxes000111 
Income (loss) from continuing operations before income taxes:560(10)215(10)(18)
Income tax expense (benefit)(4)(14)33(4)87
Net income (loss):147(7)511(3)(11)
Net income attributable to noncontrolling interest021    
Net income (loss) available to common stockholders, diluted:149(6)511(3)(11)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):147(7)511(3)(11)
Other comprehensive loss      (2)
Comprehensive income (loss):147(7)511(3)(12)
Comprehensive income, net of tax, attributable to noncontrolling interest021    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(1)(2)3(2)(1) 
Comprehensive income (loss), net of tax, attributable to parent:248(8)78(4)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: